Article
Former US Intel Officials: Dangerous Talk Of Putin's 'Loss' In Ukraine
Former US Intel Officials: Dangerous Talk Of Putin's 'Loss' In Ukraine
Authored by Veteran Intelligence Professionals for Sanity
MEMORANDUM FOR: The President
FROM: Veteran Intelligence Professionals for Sanity (VIPS)
SUBJECT: Dangerous Talk of Putin’s ‘Loss’ in Ukraine
VIPS tells President Trump that once apprised of the reality on the ground (and in the air) by his intelligence advisors, he might choose to do what is in his power to end the disaster in Ukraine.
Dear President Trump:
The New York Times is reporting that the outlook for Russia in Ukraine is “bleak.” C.I.A. Director John Ratcliffe is said to have explained that...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jul 24, 2026 / Tyler Durden
"The Polycrisis Of 2026 Whirls Like A Demon-Infested Storm Overcoming This Human Project..."
"The Polycrisis Of 2026 Whirls Like A Demon-Infested Storm Overcoming This Human Project..."
Authored by James Howard Kunstler,
Struggle session
“. . .there is no saving the Left. There is only saving America from them.” — Sasha Stone
The polycrisis of 2026 whirls like a demon-infested storm overcoming this human project of ours like a medieval panorama of the world’s end. Everything is fraught, tilting toward hazard, menace, ruin. Even under a summer sun, the mind sees only darkness everywhere it looks.
Apocalypse now, it seems like.
You almost can’t blame the doomers, the black...
Read more
May 12, 2026 / Tyler Durden
HIMS Shares Plunge As Pivot To Branded GLP-1s Weighs On Outlook
HIMS Shares Plunge As Pivot To Branded GLP-1s Weighs On Outlook
Hims & Hers shares tumbled in premarket trading in New York, the most in three months, after the company posted a first-quarter loss and revenue that missed analyst estimates tracked by Bloomberg, as costs rose amid a massive pivot from selling copycat GLP-1 drugs toward branded obesity drugs from Novo Nordisk and Eli Lilly.
Revenue for the first quarter came in at $608 million versus the $617.5 million Bloomberg Consensus estimate, while the telehealth firm swung to a loss of...
Read more
Aug 20, 2026 / Tyler Durden
Broadcom CDS Explodes As It Seeks Up To $100 Billion In Massive Off-Balance Sheet Debt Deal




